Number of the records: 1  

Succinobucol’s New Coat - Conjugation with Steroids to Alter Its Drug Effect and Bioavailability

  1. 1.
    SYSNO ASEP0368252
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSuccinobucol’s New Coat - Conjugation with Steroids to Alter Its Drug Effect and Bioavailability
    Author(s) Jurček, Ondřej (UEB-Q)
    Ikonen, S. (FI)
    Buřičová, Lucie (UEB-Q)
    Wimmerová, Martina (UEB-Q)
    Wimmer, Zdeněk (UEB-Q) RID, ORCID
    Drašar, P. (CZ)
    Horníček, Jan (UOCHB-X)
    Galandáková, A. (CZ)
    Ulrichová, J. (CZ)
    Kolehmainen, E. T. (FI)
    Source TitleMolecules. - : MDPI
    Roč. 16, č. 11 (2011), s. 9404-9420
    Number of pages17 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordssuccinobucol ; phytosterol ; atherosclerosis
    Subject RIVCC - Organic Chemistry
    R&D Projects2B06024 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    OC10001 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GA203/09/2037 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50380511 - UEB-Q (2005-2011)
    AV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000297697200038
    DOI10.3390/molecules16119404
    AnnotationSynthesis, detailed structural characterization (X-ray, NMR, MS, IR, elemental analysis), and studies of toxicity, antioxidant activity and bioavailability of unique potent anti-atherosclerotic succinobucol-steroid conjugates are reported. The conjugates consist of, on one side, the therapeutically important drug succinobucol ([4-{2,6-di-tert-butyl-4-[(1-{[3-tert-butyl-4-hydroxy-5-(propan-2-yl)phenyl]sulfanyl}ethyl)sulfanyl]phenoxy}-4-oxo-butanoic acid]) possessing an antioxidant and anti-inflammatory activity, and on the other side, plant stanol/sterols (stigmastanol, β-sitosterol and stigmasterol) possessing an ability to lower the blood cholesterol level. A cholesterol-succinobucol prodrug was also prepared in order to enhance the absorption of succinobucol through the intestinal membrane into the organism and to target the drug into the place of lipid metabolism—The enterohepatic circulation system.
    WorkplaceInstitute of Experimental Botany
    ContactDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.